Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Peripheral neuropathies: Subcutaneous immunoglobulin

Literature DB >> 29326423

Peripheral neuropathies: Subcutaneous immunoglobulin - the future of CIDP treatment?

Benjamin R Wakerley¹, Nobuhiro Yuki².

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2018 PMID： 29326423 DOI： 10.1038/nrneurol.2017.179

Source DB: PubMed Journal: Nat Rev Neurol ISSN： 1759-4758 Impact factor: 42.937

× No keyword cloud information.

10 in total

Review 1. Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis.

Authors: Bianca van den Berg; Christa Walgaard; Judith Drenthen; Christiaan Fokke; Bart C Jacobs; Pieter A van Doorn
Journal: Nat Rev Neurol Date: 2014-07-15 Impact factor: 42.937

Review 2. Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews.

Authors: Anne Louise Oaklander; Michael Pt Lunn; Richard Ac Hughes; Ivo N van Schaik; Chris Frost; Colin H Chalk
Journal: Cochrane Database Syst Rev Date: 2017-01-13

3. Monitoring intravenous immunoglobulin dosing regimens in chronic inflammatory demyelinating polyneuropathy: search for a biomarker.

Authors: Benjamin R Wakerley; Nobuhiro Yuki
Journal: J Neurol Neurosurg Psychiatry Date: 2013-04-20 Impact factor: 10.154

4. Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial.

Authors: Ivo N van Schaik; Vera Bril; Nan van Geloven; Hans-Peter Hartung; Richard A Lewis; Gen Sobue; John-Philip Lawo; Michaela Praus; Orell Mielke; Billie L Durn; David R Cornblath; Ingemar S J Merkies
Journal: Lancet Neurol Date: 2017-11-06 Impact factor: 44.182

5. Inflammatory infiltrates in sural nerve biopsies in Guillain-Barre syndrome and chronic inflammatory demyelinating neuropathy.

Authors: B Schmidt; K V Toyka; R Kiefer; J Full; H P Hartung; J Pollard
Journal: Muscle Nerve Date: 1996-04 Impact factor: 3.217

6. Pharmacokinetics of subcutaneous immunoglobulin and their use in dosing of replacement therapy in patients with primary immunodeficiencies.

Authors: Melvin Berger; Mikhail Rojavin; Peter Kiessling; Othmar Zenker
Journal: Clin Immunol Date: 2011-01-23 Impact factor: 3.969

Review 7. Subcutaneous versus intravenous immunoglobulin for chronic autoimmune neuropathies: A meta-analysis.

Authors: Juan M Racosta; Luciano A Sposato; Kurt Kimpinski
Journal: Muscle Nerve Date: 2017-02-09 Impact factor: 3.217

8. Autoantibody responses to nodal and paranodal antigens in chronic inflammatory neuropathies.

Authors: E K Mathey; N Garg; S B Park; T Nguyen; S Baker; N Yuki; C Yiannikas; C S Lin; J M Spies; R Ghaoui; M H Barnett; S Vucic; J D Pollard; M C Kiernan
Journal: J Neuroimmunol Date: 2017-05-13 Impact factor: 3.478

9. Bioavailability of IgG administered by the subcutaneous route.

Authors: Melvin Berger; Stephen Jolles; Jordan S Orange; John W Sleasman
Journal: J Clin Immunol Date: 2013-03-01 Impact factor: 8.317

Review 10. Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype.

Authors: Emily K Mathey; Susanna B Park; Richard A C Hughes; John D Pollard; Patricia J Armati; Michael H Barnett; Bruce V Taylor; P James B Dyck; Matthew C Kiernan; Cindy S-Y Lin
Journal: J Neurol Neurosurg Psychiatry Date: 2015-02-12 Impact factor: 10.154